"10.1371_journal.pone.0120232","plos one","2015-03-19T00:00:00Z","Samia Mourah; Marc G Denis; Fabienne Escande Narducci; JÃ©rÃ´me Solassol; Jean-Louis Merlin; Jean-Christophe Sabourin; Jean-Yves Scoazec; Lâ€™Houcine Ouafik; Jean-FranÃ§ois Emile; Remy Heller; Claude Souvignet; LoÃ¯c Bergougnoux; Jean-Philippe Merlio","Department of Pharmacology-Genetics, AP-HP, Saint-Louis Hospital, Paris, France; INSERM UMRS 976 Paris, F-75010, France; Department of Biochemistry, Nantes University Hospital, Nantes, France; Department of Molecular Biology and Biochemistry, Lille Regional University Hospital, Lille, France; Department of Biologyâ€Pathology, Montpellier University Hospital, Montpellier, France; Department of Tumor Biology, Alexis Vautrin Center, Vandoeuvre les Nancy, France; Department of Pathologyâ€Cytopathology, Rouen University Hospital, Rouen, France; Laboratory of Pathology and Cytopathology, Edouard Herriot Hospital, Lyon, France; Department of Biology and Pathology, Gustave Roussy Hospital, Villejuif, France; Department of Cancer Biology, Marseille Nord University Hospital, Marseille, France; Department of Pathology, Ambroise ParÃ© Hospital, Boulogne-Billancourt, France; Department of Microbiology and Molecular Biology, Colmar hospital, Colmar, France; Roche, Boulogne-Billancourt, France; Department of Tumor Biology, Bordeaux University Hospital, Bordeaux, France","Conceived and designed the experiments: SM MD JCS JYS JPM LHO. Performed the experiments: SM MD FEN JS JLM JCS JYS LHO JFE RH CS LB JPM. Analyzed the data: SM MD FEN JS JLM JCS JYS LHO JFE RH CS LB JPM. Contributed reagents/materials/analysis tools: SM MD FEN JS JLM JCS JYS LHO JFE RH JPM. Wrote the paper: SM MD FEN JS JLM JCS JYS LHO JFE RH CS LB JPM.","The authors have read the journals policy and have the following competing interests: SM: Scientific committee board membership Parafâ€™in study. Consulting fees or other remuneration: Roche, Novartis, GSK. MD: Scientific committee board membership Parafâ€™in study. Consulting fees or other remuneration: Roche, Astra-Zeneca, Boehringer Ingelheim, Qiagen. JLM: Consulting fees or other remuneration, Roche; Other, amgen, bayer, GSK, Lilly, Merck-Serono, Novartis, Roche, Sanofi. JCS: Consulting fees or other remuneration, Roche, Boehringer Ingelmen, Merck; Research grants, Roche; Other, Amgen. JYS: Research grants, Novartis, Ipsen; Consulting fees or other remuneration, Roche. FEN, JS, LHO: none. JFE: Research grants, Roche; Consulting fees or other remuneration, Roche. RH: Research grants, Roche. LB, CS: Employee, Roche. JPM: Scientific committee board membership Parafâ€™in study. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","03","Samia Mourah","SM",13,TRUE,6,13,13,13,TRUE,TRUE,FALSE,0,NA,FALSE
